A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Clinical trial NCT06041516 · RECRUITING

Trial details

NCT number: NCT06041516
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Carcinomas Neuroendocrine Tumors Carcinoma, Neuroendocrine Carcinoma, Adrenocortical Carcinoma, Adrenal Cortical

Start date: 2024-06-17
Primary completion: 2027-10-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.